SAI MedPartners Acquires The Dunn Group
December 4, 2025
SAI MedPartners, a Northlane Capital Partners-backed healthcare consultancy, has acquired The Dunn Group, a Totowa, New Jersey-based competitive intelligence firm focused on pharmaceuticals, biotechnology, and medical devices. The acquisition expands SAI's competitive intelligence capabilities and deepens its life sciences market research and analytics offerings.
- Buyers
- SAI MedPartners
- Targets
- The Dunn Group
- Platforms
- SAI MedPartners
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
SAI MedPartners Acquires Fulcrum Research Group
January 4, 2023
Healthcare Services
SAI MedPartners, a consultancy backed by Northlane Capital Partners, has acquired Fulcrum Research Group, a Waltham, MA-based primary market research firm focused on healthcare and biopharma. The add-on expands SAI's strategic insights and primary research capabilities to better serve pharmaceutical, biotechnology, and medical device clients.
-
Northlane Capital Partners Invests in SAI MedPartners
June 7, 2022
Healthcare Services
Northlane Capital Partners has made an investment in SAI MedPartners, a life-sciences consultancy providing competitive intelligence, strategy, and analytics to pharmaceutical, biotechnology, and medical device companies. The investment, made in partnership with SAI management led by Founder and CEO Erik Nordhoy, will support expansion of SAI's service offerings and global growth. SAI is headquartered in Reading, Pennsylvania and has more than 180 employees across the United States, Europe, and Asia.
-
SAI MedPartners Acquires IDEA Pharma
November 14, 2024
Healthcare Services
SAI MedPartners, a global life-sciences consultancy backed by Northlane Capital Partners, has acquired London-headquartered IDEA Pharma to strengthen its pharmaceutical path-to-market, clinical development, and commercialization capabilities. The acquisition is an add-on to SAI's platform, expanding its strategic services offering to biopharma and medical device clients.
-
SAI MedPartners Acquires PharmaForce International
March 29, 2023
Healthcare Services
SAI MedPartners, a consultancy focused on strategic insights and analytics for the pharmaceutical, biotech, and medical device industries, has acquired PharmaForce International, a Reading, Pennsylvania–based market intelligence and syndicated research firm. The acquisition adds PharmaForce's commercial benchmarking and syndicated research capabilities to SAI's competitive intelligence offerings; SAI is PE-backed by Northlane Capital Partners (which partnered with management to acquire SAI in June 2022).
-
KaarTech Acquires Dunn Solutions Group Inc.
September 25, 2023
IT Services
KaarTech, a global digital transformation and SAP-focused consulting firm, has acquired Dunn Solutions Group Inc., a Chicago-based digital commerce and customer experience consultancy. The deal expands KaarTech's customer experience and digital commerce capabilities and extends its geographic footprint in the United States and India; the transaction was facilitated by Eiliant Advisors.
-
SSI Strategy Acquires NDA Group AB
August 15, 2023
Healthcare Services
SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.